Encephalitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
We describe the case of a 29-year-old male with NMDAR encephalitis and overlapping MOG antibody disease.
|
31837635 |
2020 |
Encephalitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Antibodies to myelin oligodendrocyte glycoprotein (MOG) have been demonstrated in patients with optic neuritis (ON), encephalitis and myelitis.
|
31641876 |
2020 |
Encephalitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Especially, patients of acute disseminated encephalomyelitis (ADEM), multiple sclerosis (MS), aquaporin-4 (AQP4) seronegative neuromyelitis optica spectrum disorder (NMOSD), monophasic or recurrent optic neuritis (ON), transverse myelitis and N-methyl-d-aspartate (NMDA) receptor encephalitis (NMDARe) can overlap with Myelin Oligodendrocyte Glycoprotein antibodies.
|
30590238 |
2019 |
Encephalitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The coexistence of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis and anti-myelin oligodendrocyte glycoprotein antibody (MOG-Ab)-associated diseases has been reported.
|
31398656 |
2019 |
Encephalitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
We implemented a preclinical scheme to foster immune tolerance to myelin oligodendrocyte glycoprotein (MOG), in a cynomolgus-macaque model of experimental autoimmune encephalomyelitis (EAE), in which administration of recombinant human MOG (rhMOG) elicits brain inflammation mediated by MOG-autoreactive CD4<sup>+</sup> lymphocytes and anti-MOG IgG.
|
31492559 |
2019 |
Encephalitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Furthermore, oral ulceration, skin lesions, and HLA-B51 might be observed nonspecifically in patients with anti-MOG antibody-associated encephalitis.
|
31279093 |
2019 |
Encephalitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The Expanded Disability Status Scale scores and the Cerebral Functional System Scores at last follow-up were lower in patients with MOG-ab-associated encephalitis than in those with AQP4-ab-associated encephalitis.
|
30133068 |
2019 |
Encephalitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
We report the clinical association of myelin-oligodendrocyte-glycoprotein (MOG) IgG-associated encephalomyelitis (MOG-EM) and anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis.
|
30599296 |
2019 |
Encephalitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this review, we discuss MOG-positive cases presenting with encephalitis, encephalopathy, or ADEM-like presentation based on recently published series.
|
30907249 |
2019 |
Encephalitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Apart from the discovery of autoantibodies affecting primarily grey matter structures and the improved clinical characterization of rare entities such as N-methyl D-aspartate receptor-R- encephalitis, important strides have also been made in autoimmune-mediated white matter diseases, including paediatric multiple sclerosis (pedMS) and other acute demyelinating syndromes (ADS) often associated with antibodies (abs) against myelin-oligodendrocyte-glycoprotein (MOG).
|
29629942 |
2018 |
Encephalitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Patients with MOG-IgG-associated disease were more likely to have seizures and encephalitis-like presentation than patients with AQP4-IgG-associated disease.
|
29131884 |
2018 |
Encephalitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
MOG-IgG is associated with a wider clinical phenotype, not limited to NMOSD, with the majority of cases presenting with optic neuritis (ON), encephalitis with brain demyelinating lesions, and/or myelitis.
|
29670575 |
2018 |
Encephalitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
In our cohorts, 11.9% patients with MOG-ab disease and 0.6% patients with NMOSD had overlapping NMDARe (P < 0.01).
|
29414288 |
2018 |
Encephalitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome.
|
28982346 |
2017 |
Encephalitis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Using cell-based assays with recombinant full-length, conformationally intact MOG, several recent studies have revealed that MOG Abs can be found in a subset of predominantly pediatric patients with acute disseminated encephalomyelitis (ADEM), aquaporin-4 (AQP4) seronegative neuromyelitis optica spectrum disorders (NMOSD), monophasic or recurrent isolated optic neuritis (ON), or transverse myelitis, in atypical MS and in <i>N</i>-methyl-d-aspartate receptor-encephalitis with overlapping demyelinating syndromes.
|
28533781 |
2017 |